{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:57:05Z","timestamp":1788573425003,"version":"build-2803163510"},"reference-count":52,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R15 CA227573"],"award-info":[{"award-number":["R15 CA227573"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Community Foundation for Brevard","award":["Finken Endowment Fund"],"award-info":[{"award-number":["Finken Endowment Fund"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>SF3B1 is a core component of the U2 spliceosome that is frequently mutated in cancer. We have previously shown that titrating the activity of SF3B1, using the inhibitor pladienolide B (PB), affects distinct steps of the heat shock response (HSR). Here, we identify other genes that are sensitive to different levels of SF3B1 (5 vs. 100 nM PB) using RNA sequencing. Significant changes to mRNA splicing were identified at both low PB and high PB concentrations. Changes in expression were also identified in the absence of alternative splicing, suggesting that SF3B1 influences other gene expression pathways. Surprisingly, gene expression changes identified in low PB are not predictive of changes in high PB. Specific pathways were identified with differential sensitivity to PB concentration, including nonsense-mediated decay and protein-folding homeostasis, both of which were validated using independent reporter constructs. Strikingly, cells exposed to low PB displayed enhanced protein-folding capacity relative to untreated cells. These data reveal that the transcriptome is exquisitely sensitive to SF3B1 and suggests that the activity of SF3B1 is finely regulated to coordinate mRNA splicing, gene expression and cellular physiology.<\/jats:p>","DOI":"10.3390\/ijms21249641","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T21:21:49Z","timestamp":1608240109000},"page":"9641","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Titration of SF3B1 Activity Reveals Distinct Effects on the Transcriptome and Cell Physiology"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9907-9502","authenticated-orcid":false,"given":"Karen S.","family":"Kim Guisbert","sequence":"first","affiliation":[{"name":"Department of Biomedical and Chemical Engineering and Sciences, Florida Institute of Technology, Melbourne, FL 32937, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isiah","family":"Mossiah","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Chemical Engineering and Sciences, Florida Institute of Technology, Melbourne, FL 32937, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Guisbert","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Chemical Engineering and Sciences, Florida Institute of Technology, Melbourne, FL 32937, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrg3778","article-title":"Context-dependent control of alternative splicing by RNA-binding proteins","volume":"15","author":"Fu","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nature07509","article-title":"Alternative isoform regulation in human tissue transcriptomes","volume":"456","author":"Wang","year":"2008","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/ng.259","article-title":"Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing","volume":"40","author":"Pan","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41580-019-0126-2","article-title":"Quality and quantity control of gene expression by nonsense-mediated mRNA decay","volume":"20","author":"Kurosaki","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-genet-111212-133424","article-title":"Organizing Principles of Mammalian Nonsense-Mediated mRNA Decay","volume":"47","author":"Popp","year":"2013","journal-title":"Annu. Rev. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1242\/jcs.181008","article-title":"Nonsense-mediated mRNA decay in humans at a glance","volume":"129","author":"Kurosaki","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.biochem.76.050106.093909","article-title":"The Nonsense-Mediated Decay RNA Surveillance Pathway","volume":"76","author":"Chang","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"aac4354","DOI":"10.1126\/science.aac4354","article-title":"In vivo aspects of protein folding and quality control","volume":"353","author":"Balchin","year":"2016","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1101\/gad.1973010","article-title":"Alternative pre-mRNA splicing regulation in cancer: Pathways and programs unhinged","volume":"24","author":"David","year":"2010","journal-title":"Genes Dev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fmolb.2018.00080","article-title":"The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer","volume":"5","author":"Younis","year":"2018","journal-title":"Front. Mol. Biosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00439-017-1789-4","article-title":"Modulation of aberrant splicing in human RNA diseases by chemical compounds","volume":"136","author":"Kataoka","year":"2017","journal-title":"Hum. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/wrna.1222","article-title":"Splicing factor mutations and cancer: Splicing factor mutations and cancer","volume":"5","author":"Yoshida","year":"2014","journal-title":"Wiley RNA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1101\/gad.2014311","article-title":"Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A","volume":"25","author":"Corrionero","year":"2011","journal-title":"Genes Dev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10615","DOI":"10.1038\/ncomms10615","article-title":"Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage","volume":"7","author":"Alsafadi","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.celrep.2015.09.053","article-title":"Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3\u2032 Splice Site Selection through Use of a Different Branch Point","volume":"13","author":"Darman","year":"2015","journal-title":"Cell Rep."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"DeBoever, C., Ghia, E.M., Shepard, P.J., Rassenti, L., Barrett, C.L., Jepsen, K., Jamieson, C.H.M., Carson, D., Kipps, T.J., and Frazer, K.A. (2015). Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3\u2032 Splice Site Selection in SF3B1-mutated Cancers. PLoS Comput. Biol., 11.","DOI":"10.1371\/journal.pcbi.1004105"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1038\/leu.2016.149","article-title":"Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes","volume":"30","author":"Dolatshad","year":"2016","journal-title":"Leukemia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","article-title":"SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma","volume":"3","author":"Furney","year":"2013","journal-title":"Cancer Discov."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/path.4483","article-title":"SF3B1 mutations constitute a novel therapeutic target in breast cancer","volume":"235","author":"Maguire","year":"2015","journal-title":"J. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/blood-2011-12-399774","article-title":"Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis","volume":"119","author":"Makishima","year":"2012","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2016.08.006","article-title":"Physiologic Expression of Sf3b1 K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation","volume":"30","author":"Obeng","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/leu.2014.170","article-title":"Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron","volume":"29","author":"Visconte","year":"2015","journal-title":"Leukemia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.tig.2017.03.001","article-title":"Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures","volume":"33","author":"Jenkins","year":"2017","journal-title":"Trends Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd3823","article-title":"The spliceosome as a target of novel antitumour drugs","volume":"11","author":"Bonnal","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.drudis.2012.07.013","article-title":"The development and application of small molecule modulators of SF3b as therapeutic agents for cancer","volume":"18","author":"Webb","year":"2013","journal-title":"Drug Discov. Today"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.7164\/antibiotics.57.188","article-title":"Pladienolides, New Substances from Culture of Streptomyces platensis Mer-11107 III. In Vitro and In Vivo Antitumor Activities","volume":"57","author":"Mizui","year":"2004","journal-title":"J. Antibiot."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1111\/j.1742-4658.2011.08387.x","article-title":"Biological validation that SF3b is a target of the antitumor macrolide pladienolide: SF3b as an antitumor target of pladienolide","volume":"278","author":"Yokoi","year":"2011","journal-title":"FEBS J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.molcel.2018.03.011","article-title":"Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds","volume":"70","author":"Cretu","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nchembio.2007.16","article-title":"Splicing factor SF3b as a target of the antitumor natural product pladienolide","volume":"3","author":"Kotake","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3324\/haematol.2014.122069","article-title":"Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B","volume":"100","author":"Kashyap","year":"2015","journal-title":"Haematologica"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1093\/nar\/gku151","article-title":"Sudemycin E influences alternative splicing and changes chromatin modifications","volume":"42","author":"Convertini","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1111\/j.1349-7006.2010.01686.x","article-title":"Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF","volume":"101","author":"Furumai","year":"2010","journal-title":"Cancer Sci."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Koga, M., Satoh, T., Takasaki, I., Kawamura, Y., Yoshida, M., and Kaida, D. (2014). U2 snRNP Is Required for Expression of the 3\u2032 End of Genes. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098015"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/s41467-017-02007-z","article-title":"Molecular basis of differential 3\u2032 splice site sensitivity to anti-tumor drugs targeting U2 snRNP","volume":"8","author":"Vigevani","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1083\/jcb.201409073","article-title":"Splicing function of mitotic regulators links R-loop\u2013mediated DNA damage to tumor cell killing","volume":"209","author":"Wan","year":"2015","journal-title":"J. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1261\/rna.065383.117","article-title":"Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping","volume":"24","author":"Wu","year":"2018","journal-title":"RNA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1261\/rna.058065.116","article-title":"Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A","volume":"23","author":"Yoshimoto","year":"2016","journal-title":"RNA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10637-019-00796-2","article-title":"Apoptosis induction and cell cycle arrest of pladienolide B in erythroleukemia cell lines","volume":"38","author":"Jorge","year":"2020","journal-title":"Investig. New Drugs"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Guisbert, K.S.K., and Guisbert, E. (2017). SF3B1 is a stress-sensitive splicing factor that regulates both HSF1 concentration and activity. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0176382"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Guisbert, E., Czyz, D.M., Richter, K., McMullen, P.D., and Morimoto, R.I. (2013). Identification of a Tissue-Selective Heat Shock Response Regulatory Network. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003466"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"A3.B.1","DOI":"10.1002\/0471142735.ima03bs111","article-title":"Trypan Blue Exclusion Test of Cell Viability","volume":"111","author":"Strober","year":"2015","journal-title":"Curr. Protoc. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jcp.21397","article-title":"bag3 gene expression is regulated by heat shock factor 1","volume":"215","author":"Franceschelli","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nmeth.1528","article-title":"Analysis and design of RNA sequencing experiments for identifying isoform regulation","volume":"7","author":"Katz","year":"2010","journal-title":"Nat. Methods"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Zhang","year":"2017","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e33178","DOI":"10.7554\/eLife.33178","article-title":"ICE1 promotes the link between splicing and nonsense-mediated mRNA decay","volume":"7","author":"Baird","year":"2018","journal-title":"eLife"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"ref_48","first-page":"1687","article-title":"The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA","volume":"12","author":"Fornerod","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/jmg.36.10.739","article-title":"A molecular investigation of true dominance in Huntington\u2019s disease","volume":"36","author":"Narain","year":"1999","journal-title":"J. Med. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/wrna.1137","article-title":"Regulation of nonsense-mediated mRNA decay","volume":"3","author":"Huang","year":"2012","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1126\/science.aay0262","article-title":"Pervasive functional translation of noncanonical human open reading frames","volume":"367","author":"Chen","year":"2020","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/24\/9641\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:46:37Z","timestamp":1760179597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/24\/9641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,17]]},"references-count":52,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["ijms21249641"],"URL":"https:\/\/doi.org\/10.3390\/ijms21249641","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,17]]}}}